IN187156B - - Google Patents

Info

Publication number
IN187156B
IN187156B IN1736CA1997A IN187156B IN 187156 B IN187156 B IN 187156B IN 1736CA1997 A IN1736CA1997 A IN 1736CA1997A IN 187156 B IN187156 B IN 187156B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN187156(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IN187156B publication Critical patent/IN187156B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN1736CA1997 1996-09-23 1997-09-19 IN187156B (US06373033-20020416-M00018.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
IN187156B true IN187156B (US06373033-20020416-M00018.png) 2002-02-16

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1736CA1997 IN187156B (US06373033-20020416-M00018.png) 1996-09-23 1997-09-19

Country Status (36)

Country Link
US (1) US6020487A (US06373033-20020416-M00018.png)
EP (1) EP0831098B1 (US06373033-20020416-M00018.png)
JP (2) JP2001500877A (US06373033-20020416-M00018.png)
KR (1) KR100560015B1 (US06373033-20020416-M00018.png)
CN (1) CN1122036C (US06373033-20020416-M00018.png)
AR (1) AR013838A1 (US06373033-20020416-M00018.png)
AT (1) ATE209208T1 (US06373033-20020416-M00018.png)
AU (1) AU719441B2 (US06373033-20020416-M00018.png)
BR (1) BR9712100A (US06373033-20020416-M00018.png)
CA (1) CA2265712C (US06373033-20020416-M00018.png)
CO (1) CO4910140A1 (US06373033-20020416-M00018.png)
CZ (1) CZ299248B6 (US06373033-20020416-M00018.png)
DE (1) DE69708428T2 (US06373033-20020416-M00018.png)
DK (1) DK0831098T3 (US06373033-20020416-M00018.png)
EA (1) EA001642B1 (US06373033-20020416-M00018.png)
EG (1) EG23861A (US06373033-20020416-M00018.png)
ES (1) ES2166051T3 (US06373033-20020416-M00018.png)
HK (1) HK1009807A1 (US06373033-20020416-M00018.png)
HU (1) HU226484B1 (US06373033-20020416-M00018.png)
ID (1) ID27275A (US06373033-20020416-M00018.png)
IL (1) IL128962A (US06373033-20020416-M00018.png)
IN (1) IN187156B (US06373033-20020416-M00018.png)
MY (1) MY125565A (US06373033-20020416-M00018.png)
NO (1) NO323980B1 (US06373033-20020416-M00018.png)
NZ (1) NZ334448A (US06373033-20020416-M00018.png)
PE (1) PE110398A1 (US06373033-20020416-M00018.png)
PL (3) PL196069B1 (US06373033-20020416-M00018.png)
PT (1) PT831098E (US06373033-20020416-M00018.png)
RS (1) RS49598B (US06373033-20020416-M00018.png)
SI (1) SI0831098T1 (US06373033-20020416-M00018.png)
SV (1) SV1997000081A (US06373033-20020416-M00018.png)
TR (1) TR199900640T2 (US06373033-20020416-M00018.png)
TW (1) TW470746B (US06373033-20020416-M00018.png)
UA (1) UA59371C2 (US06373033-20020416-M00018.png)
WO (1) WO1998012199A1 (US06373033-20020416-M00018.png)
ZA (1) ZA978515B (US06373033-20020416-M00018.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0114031A (pt) * 2000-08-31 2003-09-09 Reddy S Lab Ltd Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
WO2003037903A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CA2471341C (en) 2001-12-24 2012-01-24 Sun Pharmaceutical Industries Limited Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
WO2003101997A1 (en) * 2002-05-31 2003-12-11 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
EP1684734A2 (en) * 2003-11-18 2006-08-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
DE602004014264D1 (de) * 2003-12-22 2008-07-17 Teva Pharma Verfahren zur herstellung von olanzapin
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
EP1716154A1 (en) * 2004-02-19 2006-11-02 Neuland Laboratories Ltd Process for the preparation of olanzapine form 1 useful as antipsychotic drug
US20080009481A1 (en) * 2004-07-14 2008-01-10 Shasun Chemicals And Drugs Limited Process For Making Form I Of Olanzapine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
US7910577B2 (en) * 2004-11-16 2011-03-22 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンii型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
AU720366B2 (en) * 1996-09-23 2000-06-01 Eli Lilly And Company Olanzapine dihydrate D

Also Published As

Publication number Publication date
NO991382D0 (no) 1999-03-22
EA199900326A1 (ru) 1999-08-26
DE69708428T2 (de) 2002-07-04
PE110398A1 (es) 1999-01-14
EP0831098A2 (en) 1998-03-25
EG23861A (en) 2007-11-18
NO323980B1 (no) 2007-07-30
NO991382L (no) 1999-03-22
AU4484197A (en) 1998-04-14
PT831098E (pt) 2002-04-29
AU719441B2 (en) 2000-05-11
SI0831098T1 (en) 2002-04-30
ID27275A (id) 2001-03-22
DK0831098T3 (da) 2002-05-21
YU15599A (sh) 2001-12-26
TR199900640T2 (xx) 1999-06-21
IL128962A (en) 2003-01-12
PL332482A1 (en) 1999-09-13
PL196069B1 (pl) 2007-12-31
DE69708428D1 (de) 2002-01-03
CN1122036C (zh) 2003-09-24
EP0831098A3 (en) 1998-04-29
JP2009242407A (ja) 2009-10-22
PL196068B1 (pl) 2007-12-31
EP0831098B1 (en) 2001-11-21
MY125565A (en) 2006-08-30
PL194565B1 (pl) 2007-06-29
TW470746B (en) 2002-01-01
IL128962A0 (en) 2000-02-17
SV1997000081A (es) 1999-01-14
RS49598B (sr) 2007-06-04
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
HK1009807A1 (en) 1999-06-11
ATE209208T1 (de) 2001-12-15
CA2265712A1 (en) 1998-03-26
JP2001500877A (ja) 2001-01-23
ZA978515B (en) 1999-03-23
HUP0000066A2 (hu) 2000-06-28
KR20000048520A (ko) 2000-07-25
CA2265712C (en) 2006-10-31
UA59371C2 (uk) 2003-09-15
HUP0000066A3 (en) 2000-11-28
AR013838A1 (es) 2001-01-31
CZ99099A3 (cs) 1999-11-17
HU226484B1 (en) 2009-03-02
EA001642B1 (ru) 2001-06-25
CO4910140A1 (es) 2000-04-24
ES2166051T3 (es) 2002-04-01
KR100560015B1 (ko) 2006-03-15
BR9712100A (pt) 1999-08-31
US6020487A (en) 2000-02-01
CN1234802A (zh) 1999-11-10
CZ299248B6 (cs) 2008-05-28

Similar Documents

Publication Publication Date Title
CY2619B2 (US06373033-20020416-M00018.png)
AR026662A2 (US06373033-20020416-M00018.png)
IN188590B (US06373033-20020416-M00018.png)
ITMC960017A0 (US06373033-20020416-M00018.png)
IN185463B (US06373033-20020416-M00018.png)
IN192927B (US06373033-20020416-M00018.png)
ITMI960264A0 (US06373033-20020416-M00018.png)
ITME960005A0 (US06373033-20020416-M00018.png)
ITCR960005V0 (US06373033-20020416-M00018.png)
ITCA960007V0 (US06373033-20020416-M00018.png)
ITMI960546V0 (US06373033-20020416-M00018.png)
IN188278B (US06373033-20020416-M00018.png)
ITMI960583A0 (US06373033-20020416-M00018.png)
IN184689B (US06373033-20020416-M00018.png)
ITMI960585A0 (US06373033-20020416-M00018.png)
ITMI960603V0 (US06373033-20020416-M00018.png)
CN3043305S (US06373033-20020416-M00018.png)
CN3047493S (US06373033-20020416-M00018.png)
CN3047788S (US06373033-20020416-M00018.png)
CN3047747S (US06373033-20020416-M00018.png)
CN3047746S (US06373033-20020416-M00018.png)
CN3045911S (US06373033-20020416-M00018.png)
CN3044347S (US06373033-20020416-M00018.png)
CN3047648S (US06373033-20020416-M00018.png)
CN3047647S (US06373033-20020416-M00018.png)